High-dose megestrol acetate. A possible treatment for cachexia.

Area of Science:

• Oncology
• Pharmacology

Background:

• Weight loss and anorexia are common, serious complications in various diseases, increasing patient morbidity.
• Cachexia, characterized by anorexia and weight loss, significantly impacts the quality of life for patients with underlying conditions like cancer.

Purpose of the Study:

• To investigate the effects of high-dose oral megestrol acetate on weight and appetite in breast cancer patients experiencing cachexia.
• To assess the potential of megestrol acetate in reversing anorexia and weight loss.

Main Methods:

• A study involving 28 breast cancer patients receiving high doses of oral megestrol acetate (480 to 1600 mg/d).
• Observation of weight changes and appetite enhancement in patients during treatment.

Main Results:

• 27 out of 28 patients (96%) experienced significant weight gain (median 5.1 kg, range 0.9-20.1 kg).
• Appetite enhancement was observed in the majority of patients.
• Weight gain was independent of initial weight, metastatic status, or treatment response.

Conclusions:

• High-dose megestrol acetate demonstrates a strong potential for reversing anorexia and promoting weight gain in breast cancer patients with cachexia.
• Megestrol acetate may serve as a therapeutic option to improve the quality of life for patients suffering from cachexia.
• Further research is warranted to elucidate the mechanisms behind megestrol acetate-induced weight gain and explore broader clinical applications.